Criticized for not doing enough to prevent the fungal meningitis outbreak, the U.S. Food and Drug Administration stepped up inspections of compounding pharmacies only to be refused access. The FDA had to get court orders to enter two pharmacies, said FDA Commissioner Margaret Hamburg. A total of four initially refused to let inspectors look at their records or watch drug production. Read the full story